Machine learning uncovers four new extracellular contractile injection-system toxins
An XGBoost classifier trained on genomic and biochemical features prioritized eCIS-associated toxins from bacterial and archaeal genomes. Four candidates, EAT14–17, were experimentally shown to be toxic in bacterial and/or yeast cells; EAT14 also inhibited Rac1/Cdc42-mediated mitogenic signaling in human cells.
Technology: XGBoost classifier for extracellular contractile injection-system-associated toxins (EATs)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Four candidates, EAT14–17, were experimentally shown to be toxic in bacterial and/or yeast cells; EAT14 also inhibited Rac1/Cdc42-mediated mitogenic signaling in human cells.
- Still unknown: Four of eight selected candidates were toxic under the tested heterologous-expression assays; the authors report an empirical positive predictive value of 50% for this sample and discuss possible host/compartment mismatch. Toxin delivery by native eCIS and physiological target organisms remain incompletely established. EAT14’s signaling effect was shown in human cells, not as a therapeutic effect.
- AI role: The classifier used genomic and protein biochemical features to score candidate EAT genes across eCIS-positive microbial genomes. The model narrowed candidates for functional tests; heterologous expression assays validated four previously uncharacterized toxins, with follow-up active-site mutations and a human-cell signaling assay.
Evidence sources: https://link.springer.com/article/10.1038/s44320-024-00053-6
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: at percentile 83 of works of the same type, year and subfield (OpenAlex work metrics, 9 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.